Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer

Clinical Trial ID NCT01216527

PubWeight™ 188.42‹?›

🔗 Visit the page for NCT01216527

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global cancer statistics. CA Cancer J Clin 2011 185.92
2 Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012 15.43
3 Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy. Ann Oncol 2014 0.91
4 Esophageal carcinoma advances in treatment results for locally advanced disease: review. Ann Oncol 2011 0.88
5 Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol 2003 0.88
6 Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status. Anticancer Res 2008 0.85
7 A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinoma. Cancer Invest 2006 0.79
8 New and emerging combination therapies for esophageal cancer. Cancer Manag Res 2013 0.77
9 [Neo-adjuvant chemoradiotherapy followed by surgery in treatment of advanced esophageal carcinoma]. Zhonghua Yi Xue Za Zhi 2008 0.75
Next 100